文献速递胸部肿瘤

国际肺癌研究协会分级系统所描述肺腺癌的临床病理与基因型特征

Clinicopathologic and Genotypic Features of Lung Adenocarcinoma Characterized by the International Association for the Study of Lung Cancer Grading System.
PubMed 文献 · J Thorac Oncol · 2022-02-25

该研究分析了781例连续浸润性非黏液性肺腺癌患者的临床病理、基因型和预后特征,按国际肺癌研究协会(IASLC)2020年病理委员会分级系统分组。3级肿瘤与年轻、男性、高吸烟量及侵袭性特征相关,无复发生存和3年总生存按分级良好分层。3级腺癌中43%缺乏驱动突变,而1或2级肿瘤中79%可检出驱动突变。年龄、吸烟史、实性结节和较高最大标准化摄取值可术前预测3级肿瘤,预测率超过90%。

要点

  • 3级肿瘤与年轻、男性、高吸烟量及侵袭性病理特征相关。
  • 无复发生存和3年总生存按IASLC分级良好分层,多因素分析证实差异。
  • 3级腺癌43%缺乏驱动突变,1或2级肿瘤79%可检出驱动突变。

核心结论

  • 新分级系统除分层患者结局外,还识别出独特的临床病理亚群,本研究提示3级肿瘤可用术前变量预测。

研究设计与样本

  • 分析781例连续浸润性非黏液性肺腺癌患者的临床病理、基因型和预后特征。

主要发现

  • 3级肿瘤与年轻年龄、男性、较高吸烟剂量及侵袭性特征(肿瘤大小、淋巴结转移、分期、淋巴血管侵犯和胸膜侵犯)相关。
  • 无复发生存和3年总生存按肿瘤分级良好分层,差异经Cox比例风险模型多因素分析证实。
  • 影像学上,多数3级肿瘤在计算机断层扫描(CT)图像上呈实性结节模式,正电子发射断层扫描(PET)最大标准化摄取值较高。
  • 基因型上,43%的3级腺癌缺乏任何驱动突变,而79%的1或2级肿瘤可检出一种驱动突变。
  • 患者年龄、阳性吸烟史、CT图像实性结节和较高最大标准化摄取值被确定为3级肿瘤的显著术前预测因素,预测率大于90%。

关键数值与推荐

  • 3级腺癌中43%缺乏驱动突变,1或2级肿瘤中79%可检出驱动突变。
  • 术前预测3级肿瘤的预测率大于90%。

临床怎么用

  • 作者认为,3级肿瘤可用年龄、阳性吸烟史、CT实性结节和较高最大标准化摄取值等术前变量进行预测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The new grading system proposed by the Pathology Committee of the International Association for the Study of Lung Cancer in 2020 was based on the combination of the histologically predominant subtype and high-grade component. Because the predominant subtypes are associated with characteristic subsets, unique subsets can be identified by this grading system. METHODS: We analyzed the clinicopathologic, genotypic, and prognostic features of a cohort of 781 consecutive patients with invasive nonmucinous adenocarcinoma of the lung. RESULTS: Grade 3 tumors were associated with younger age, male sex, a higher smoking dose, and aggressive features (tumor size, lymph node metastasis, stage, lymphovascular invasion, and pleural invasion). Recurrence-free survival and 3-year overall survival were well-stratified according to tumor grade, and the differences were confirmed with multivariate analysis using the Cox proportional hazard model. Radiologically, most grade 3 tumors exhibit a solid nodular pattern on computed tomography images and a high maximum standardized uptake value with positron emission tomography. Genotypically, 43% of the grade 3 adenocarcinomas lacked any driver mutations, although one of the driver mutations was detected in 79% of grade 1 or 2 tumors. Patient age, positive smoking history, solid nodule on computed tomography image, and higher maximum standardized uptake value were identified as significant preoperative predictive factors of grade 3 tumors, with a prediction rate greater than 90%. CONCLUSIONS: Besides stratifying the patient outcomes, the new grading system characterized unique clinicopathologic subsets and this study suggested that grade 3 tumors could be predicted using the preoperative variables.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Fujikawa R, Muraoka Y, Kashima J, et al. Clinicopathologic and Genotypic Features of Lung Adenocarcinoma Characterized by the International Association for the Study of Lung Cancer Grading System. J Thorac Oncol. 2022. PMID: 35227909. doi:10.1016/j.jtho.2022.02.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。